Zhejiang Sunflower Light Energy (300111) fair value: what the stock is really worth
As of Sep 22, 2026: fair value of Zhejiang Sunflower Light Energy ¥0.57, price ¥3.12, upside -81.7%, quality 36 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Zhejiang Sunflower Light Energy for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range ¥1.87 – ¥9.43 · fair‑value band ¥0.5400 – ¥0.6000 · the ¥3.12 price screens above the ¥0.5700 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Zhejiang Sunflower Light Energy in your weekly email
Every Wednesday you see whether Zhejiang Sunflower Light Energy is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally.
Show more
Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pneumonia, and urethritis and cervicitis; and azithromycin dispersible tablets and injections for sinusitis, acute otitis media, acute bronchitis, acute exacerbation of chronic bronchitis, streptococcus pneumoniae, pneumonia, haemophilus influenzae, mycoplasma pneumoniae, urethritis, cervicitis and skin and soft tissue infection. The company also provides roxithromycin capsules to treat pharyngitis and tonsillitis caused by Streptococcus pyogenes, sinusitis, otitis media, acute bronchitis, acute exacerbation, as well as urethritis, cervicitis, and skin and soft tissue infection. In addition, it offers lacidipine dispersible tablets for the treatment of high blood pressure; and simvastatin tablets used for hyperlipidemia, coronary heart disease combined with hypercholesterolemia, and children with heterozygous familial hypercholesterolemia. Further, the company provides omeprazole sodium for injection, a digestive system drug, used as an alternative therapy for duodenal ulcer, gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome; and famotidine for injection for treatment of peptic ulcer bleeding, acute gastric mucosal damage, and gastrointestinal bleeding caused by non-steroidal anti-inflammatory drugs. The company was formerly known as Zhejiang Sunflower Great Health Limited Liability Company and changed its name to Zhejiang Sunflower Great Health Co., Ltd. in December 2023. Zhejiang Sunflower Great Health Co., Ltd. was founded in 2005 and is headquartered in Shaoxing, China.
Stock analysis
Zhejiang Sunflower Light Energy (300111) currently trades at ¥3.12, while our model-based Fair Value estimate is ¥0.5700, implying the stock looks roughly 447.3% overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ¥0.4300 per share, and 0 of the 3 models we run sit above the ¥3.12 price.
Bear case: the DCF Models group reads lowest at ¥0.3100, and 3 of the 3 models stay below the price. Evidence for this calculation is low.
Scenario range: ¥0.5400 (bear) to ¥0.6000 (bull), the price of ¥3.12 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Zhejiang Sunflower Light Energy reported revenue of 272M CNY in FY2025 versus 297M CNY in FY2021, a compound −2.2%/yr. Reported net income was −4.4M CNY in FY2025.
Key figures
Market cap 4.0B CNY (≈ $600M) · P/S ratio 15.8 · EPS (TTM) ¥−0.0100 · Net margin −1.6% · Return on equity −1.0% · Return on assets (EBIT) 2.5% · Operating margin −9.3% · Revenue (TTM) 254M CNY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 67% below its 52-week high and 20% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at −82%, 300111 screens richer than that median.
Fair Value models
Bear ¥0.5400Fair Value ¥0.5700Bull ¥0.6000
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.2/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−17.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.1%
Start year 2020 (pandemic). Over 10 years: −17.3% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.2%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
25.7% (2020) → −2.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Zhejiang Sunflower Light Energy with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 612 stocks
Beats the industry median on 1/9 measures
Overall it trails its industry peers.
Valuation
Quality Score36 · Bottom 25%
Fair Value upside−82% · Bottom 25%
Profitability
Return on assets−1% · Bottom 25%
Net margin (TTM)−4% · Below median
Operating margin (TTM)−9% · Bottom 25%
Growth and dividend
Revenue growth−25% · Bottom 25%
Balance sheet
Debt / equity0.18× · Above median
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
P/B0.88× · Cheaper than median
P/S (TTM)2.36× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 12
FUTURE (revenue growth)0· sector 21
PAST (return on equity)0· sector 25
HEALTH (low debt)91· sector 96
DIVIDEND (yield)0· sector 30
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Zhejiang Sunflower Light Energy Fair Value". https://www.fairvalue-calculator.com/stock/300111
Frequently asked questions
Is Zhejiang Sunflower Light Energy (300111) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of ¥0.5700 versus a price of ¥3.12, about −82% upside (overvalued).
What is the fair value of 300111?
Our model-based fair value for Zhejiang Sunflower Light Energy is ¥0.5700 (as of Sep 23, 2026), built from audited fundamentals. The current price: ¥3.12.
What is the quality score of 300111?
Zhejiang Sunflower Light Energy has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Zhejiang Sunflower Light Energy (300111)?
Our model-based price target is the fair value of ¥0.5700 (as of Sep 23, 2026) from 3 valuation models. Cautious scenario ¥0.5400, optimistic scenario ¥0.6000. It is a calculation from audited fundamentals, not an analyst target.
What is the Zhejiang Sunflower Light Energy stock forecast for 2026?
Our models put fair value at ¥0.5700, about −82% upside versus a price of ¥3.12 (overvalued). Cautious scenario ¥0.5400, optimistic scenario ¥0.6000. The calculation is refreshed regularly with new filings.
What is the revenue of Zhejiang Sunflower Light Energy (300111)?
Zhejiang Sunflower Light Energy reported trailing-twelve-month revenue of about 254M CNY (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of Zhejiang Sunflower Light Energy (300111)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Zhejiang Sunflower Light Energy it is ¥0.5700 per share (as of Sep 23, 2026), against a price of ¥3.12. It is the blended result of 3 valuation models (cash flow, earnings, asset, dividend).
Is Zhejiang Sunflower Light Energy stock overvalued or undervalued in 2026?
As of Sep 23, 2026, 300111 trades above its calculated fair value: price ¥3.12, fair value ¥0.5700, a gap of about −82% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 300111?
No. The price is what the market pays today (¥3.12); the fair value is what the company's own numbers justify (¥0.5700). For Zhejiang Sunflower Light Energy the two are ¥2.55 per share apart. That gap is exactly why we show both numbers side by side.
How much is Zhejiang Sunflower Light Energy worth?
The market values Zhejiang Sunflower Light Energy at about 4.0B CNY (market capitalisation, as of Sep 23, 2026). Per share that is ¥3.12; our models calculate a fair value of ¥0.5700 per share.
What do the bullish and bearish scenarios say about 300111?
Our models span a range for Zhejiang Sunflower Light Energy: cautious scenario ¥0.5400, base ¥0.5700, optimistic ¥0.6000 per share (as of Sep 23, 2026, price ¥3.12). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Zhejiang Sunflower Light Energy (300111)?
Balance-sheet figures for Zhejiang Sunflower Light Energy (as of Sep 23, 2026): return on equity −1.0%, debt of 0.18 per unit of equity. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is 300111 from its 52-week high?
Zhejiang Sunflower Light Energy trades at ¥3.12, about 67% below its 52-week high of ¥9.43 and 20% above the low of ¥2.61 (as of Sep 22, 2026). Distance from the high says nothing about value: that is what the fair value of ¥0.5700 is for.
Which stocks are comparable to Zhejiang Sunflower Light Energy?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Jiangsu Hengrui Pharmaceuticals Co, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Zhejiang Sunflower Light Energy stock attractive at the current price?
The data as of Sep 23, 2026: price ¥3.12, calculated fair value ¥0.5700 (−82%), Quality Score 36/100, from 3 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 300111 calculated?
We run Zhejiang Sunflower Light Energy through 3 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥0.5700, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Zhejiang Sunflower Light Energy itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Zhejiang Sunflower Light Energy (300111)?
The closing price on Sep 22, 2026 was ¥3.12. Our model-based fair value is ¥0.5700, about −82% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Zhejiang Sunflower Light Energy right now?
The price sits above even our optimistic bull case (¥0.6000). The favourable scenario is already priced in. Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. The models converge in a tight band (¥0.5400 to ¥0.6000), unusually little disagreement for a valuation.
Where does the earnings growth of Zhejiang Sunflower Light Energy (300111) come from?
Earnings per share at Zhejiang Sunflower Light Energy grew −14.3 % a year from 2013 to 2024. Broken into its drivers: revenue per share −16.1 %, EBIT margin +5.3 %, tax rate +1.2 %, residual (interest, one-offs) −4.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Zhejiang Sunflower Light Energy
How large is the market capitalisation of Zhejiang Sunflower Light Energy (300111)?
The market capitalisation of Zhejiang Sunflower Light Energy is 4.0B CNY (≈ $600M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Zhejiang Sunflower Light Energy (300111)?
The price-to-sales ratio of Zhejiang Sunflower Light Energy is 15.8 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Zhejiang Sunflower Light Energy (300111)?
Earnings per share at Zhejiang Sunflower Light Energy are ¥−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Zhejiang Sunflower Light Energy (300111)?
The net margin of Zhejiang Sunflower Light Energy is −1.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Zhejiang Sunflower Light Energy (300111)?
The return on equity (ROE) of Zhejiang Sunflower Light Energy is −1.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Zhejiang Sunflower Light Energy (300111)?
On an EBIT basis the return on assets of Zhejiang Sunflower Light Energy is 2.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Zhejiang Sunflower Light Energy (300111)?
The operating margin of Zhejiang Sunflower Light Energy is −9.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Zhejiang Sunflower Light Energy (300111)?
Revenue at Zhejiang Sunflower Light Energy is growing −24.5% versus a year earlier (3y avg −6.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Zhejiang Sunflower Light Energy (300111)?
Earnings per share at Zhejiang Sunflower Light Energy are growing −94.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Zhejiang Sunflower Light Energy (300111) generate?
The free cash flow of Zhejiang Sunflower Light Energy is −5.6M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Zhejiang Sunflower Light Energy (300111) hold?
Zhejiang Sunflower Light Energy holds more cash than debt, 563M CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Zhejiang Sunflower Light Energy in the live analysis
One click puts Zhejiang Sunflower Light Energy on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
